Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: The role of nitric oxide

Journal of Immunology

Volumn 162, Issue 9, 1999, Pages 5270-5277

  Lasarte, Juan José ^a   Corrales, Fernando José ^a   Casares, Noelia ^a   López Díaz De Cerio, Ascensión ^a   Qian, Cheng ^a   Xie, Xiaoming ^a   Borrás Cuesta, Francisco ^a   Prieto, Jesús ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUTATHIONE; INTERLEUKIN 12; INTERLEUKIN 2; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; VIRUS ANTIGEN; VIRUS PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME INHIBITION; GENE TRANSFER; HEPATITIS C VIRUS; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS IMMUNITY;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; APOPTOSIS; DEFECTIVE VIRUSES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEPACIVIRUS; IMMUNOGLOBULIN G; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE II; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PERITONEAL CAVITY; RECOMBINATION, GENETIC; SPLEEN; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VIRAL CORE PROTEINS; VIRAL ENVELOPE PROTEINS;

EID: 0033136294     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Sher, A., and R. L. Coffman. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10:385.
2. Scott, P., and G. Trinchieri. 1997. IL-12 as an adjuvant for cell-mediated immunity. Semin. Immunol. 9:285.
3. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immune-regulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
4. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
5. Afonso, L. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235.
6. Mougneau, E., F. Altare, A. E. Wakil, S. Zheng, T. Coppola, Z. E. Wang, R. Waldmann, R. M. Locksley, and N. Glaichenhaus. 1995. Expression cloning of a protective Leishmania antigen. Science 268:563.
7. Nabors, G. S., L. C. Afonso, J. P. Farrell, and P. Scott. 1995. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proc. Natl. Acad. Sci. USA 92:3142.
8. Mountford, A. P., S. Anderson, and R. A. Wilson. 1996. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant. J. Immunol. 156:4739.
9. Schijns, V. E., B. L. Haagmans, and M. C. Horzinek. 1995. IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-γ-receptor-deficient mice. J. Immunol. 155:2525.
10. Tang, Y. W., and B. S. Graham. 1995. Interleukin-12 treatment during immunization elicits a T helper cell type 1 -like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. J. Infect. Dis. 172:734.
11. Brunda, M. J., L. Luistro, R. R. Warner, R. B. Wright, B. R. Hubbard, M. Murphy, S. F. Wolf, and M. K. Gately. 1993. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178:1223.
12. Nastala, C. L., H. D. Edington, T. G. McKinney, H. Tahara, M. A. Nalesnik, M. J. Brunda, M. K. Gately, S. F. Wolf, R. D. Schreiber, W. J. Storkus, et al. 1994. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153:1697.
13. Zou, J. P., N. Yamamoto, T. Fujii, H. Takenaka, M. Kobayashi, S. H. Herrmann, S. F. Wolf, H. Fujiwara, and T. Hamaoka. 1995. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by antitumor T cells. Int. Immunol. 7:1135.
14. Orange, J. S., S. F. Wolf, and C. A. Biron. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. Immunology 152:1253.
15. Schwacha, M. G., and T. K. Eisenstein. 1997. Inlerleukin-12 is critical for in-duction of nitric oxide-mediated immunosuppression following vaccination of mice with attenuated Salmonella typhimurium. Infect. Immun. 65:4897.
16. Ryffel, B. 1997. Interleukin-12: role of interferon-γ in IL-12 adverse effects. Clin. Immunol. Immunopathol. 83:18.
17. Shurin, M. R., C. Esche, J. M. Peron, and M. T. Lotze. 1996. Antitumor activities of IL-12 and mechanisms of action. Chem. Immunol. 68:153.
18. Caruso, M., K. Pham-Nguyen, Y. L. Kwong, B. Xu, K. I. Kosai, M. Finegold, S. L. Woo, and S. H. Chen. 1996. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc. Natl. Acad. Sci. USA 93:11302.
19. Addison, C. L., J. L. Bramson, M. M. Hitt, W. J. Muller, J. Gauldie, and F. L. Graham. 1998. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors. Gene Ther. 5:1400.
20. Bruña-Romero, O., J. J. Lasarte, G. W. G. Wilkinson, K. Grace, E. D'Souza, B. E. Clarke, F. Borrás-Cuesla, and J. Prieto. 1997. In vivo induction of cytotoxic T lymphocytes against hepatitis C virus protein using a replication deficient adenovirus recombinant or a synthetic peptide. Hepatology 25:470.
21. + T cells correlates with Th1/Th2 phenotype. J. Immunol. 160:5347.
22. Taylor-Robinson, A. W. 1997. Counter-regulation of T helper 1 cell proliferation by nitric oxide and interleukin-2. Biochem. Biophys. Res. Commun. 233:14.
23. Chang, R. H., M. H. Feng, W. H. Liu, and M. Z. Lai. 1997. Nitric oxide increased interleukin-4 expression in T lymphocytes. Immunology 90:364.
24. Liew, F. Y. 1995. Regulation of lymphocyte functions by nitric oxide. Curr. Opin. Immunol. 7:396.
25. Bauer, H., T. Jung, D. Tsikas, D. O. Stichtenoth, J. C. Frolich, and C. Neumann. 1997. Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology 90:205.
26. Lander, H. M., P. Sehajpal, D. M. Levine, and A. Novogrodsky. 1993. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1509.
27. Merrifield, R. B. 1963. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 18:80.
28. Atherton, E., J. C. Logan, and R. C. Sheppard. 1981. Peptide synthesis. Part 2. Procedures for solid phase synthesis using N-fluorenil metoxicarbonil aminoacids on polyamide supports: synthesis of substance P and of acyl carrier protein 65-74 decapeptide. J. Chem. Soc. Perkin Trans. 1:538.
29. Kaiser, E., R. L. Colescott, C. D. Bossinger, and P. I. Cook. 1970. Color test for detection of free terminal amino groups in the solid phase synthesis of peptides. Anal. Biochem. 34:595.
30. Lai, M. Z., D. T. Ross, J. G. Guillet, T. J. Briner, M. L. Gefter, and J. A. Smith. 1987. T lymphocyte response to bacteriophage λ repressor cI protein: recognition of the same peptide presented by Ia molecules of different haplotypes. J. Immunol. 139:3973.
31. Brunner, K. T., J. Mauel, J. C. Cerottini, and B. Chapuis. 1968. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14:181.
32. Waldmann, H., W. J. Penhale, and J. D. Sedgwick. 1987. Limiting dilution analysis. In: Lymphocytes: a Practical Approach. Klaus, G. G. B. ed. IRL Press, Oxford U.K., p. 163.
33. Reed, D. J., J. R. Babson, P. W. Beatty, A. E. Brodie, W. W. Ellis, and D. W. Potter. 1980. High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfldes. Anal. Biochem. 106:55.
34. Inchauspe, G., L. Vitvitski, M. E. Major, G. Jung, U. Spengler, M. Maisonnas, and C. Trepo. 1997. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol. 16:185.
35. Major, M. E., L. Vitvitski, M. A. Mink, M. Schleef, R. G. Whalen, C. Trepo, and G. Inchauspe. 1995. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J. Virol. 69:5798.
36. McLaughlin, K. A., B. A. Osborne, and R. A. Goldsby. 1996. The role of oxygen in thymocyte apoptosis. Eur. J. Immunol. 26:1170.
37. Ma, X., A., D'Andrea, M. Kubin, M. Aste-Amezaga, A. Sartori, J. Monteiro, L. Showe, M. Wysocka, and G. Trinchieri. 1995. Production of interleukin-12. Res. Immunol. 146:432.
38. + CTL responses in vitro. J. Clin. Invest. 98:715.
39. Waldburger, K. E., R. C. Hastings, R. G. Schaub, S. J. Goldman, and J. P. Leonard. 1996. Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12: preferential expansion of Interferon-γ-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulalory mechanisms. Am. J. Pathol. 148:375.
40. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323.
41. Rockett, K. A., M. M. Awburn, E. J. Rockett, W. B. Cowden, and I. A. Clark. 1994. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol. 16:243.
42. Taylor-Robinson, A. W., F. Y. Liew, A. Severn, D. Xu, S. J. McSorley, P. Garside, J. Padron, and R. S. Phillips. 1994. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24:980.
43. Chang, R. H., M. H. Feng, W. H. Liu, and M. Z. Lai. 1997. Nitric oxide increased interleukin-4 expression in T lymphocytes. Immunology 90:364.
44. Genaro, A. M., S. Hortelano, A. Alvarez, C. Martinez, and L. Bosca. 1995. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J. Clin. Invest. 95:1884.
45. Mannick, J. B., K. Asano, K. Izumi, E. Kieff, and J. S. Stamler. 1994. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79:1137.
46. Matthys, P., G. Froyen, L. Verdot, S. Huang, H. Sobis, J. Van Damme, B. Vray, M. Aguet, and A. Billiau. 1995. IFN-γ receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis: protective role of endogenous nitric oxide. J. Immunol 155:3823.
47. Lander, H. M., P. Sehajpal, D. M. Levine, and A. Novogrodsky. 1993. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1509.
48. Sriskandan, S., T. J. Evans, and J. Cohen. 1996. Bacterial superantigen-induced human lymphocyte responses are nitric oxide dependent and mediated by IL-12 and IFN-γ. J Immunol. 156:2430.
49. Peterson, J. D., L. A. Herzenberg, K. Vasquez, and C. Waltenbaugh. 1998. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc. Natl. Acad. Sci. USA 95:3071.
50. Nakamura, H., K. Nakamura, and J. Yodoi. 1997. Redox regulation of cellular activation. Annu. Rev. Immunol. 15:351.